Stay updated on Margetuximab vs Trastuzumab in HER2+ Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Margetuximab vs Trastuzumab in HER2+ Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Margetuximab vs Trastuzumab in HER2+ Metastatic Breast Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The page shows a new Revision: v3.6.5 label, replacing the previous v3.6.4 label; this reflects an update to the page's metadata rather than a change to the study details.
    Difference
    0.0%
    Check dated 2026-08-08T23:36:20.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page shows a new Revision: v3.6.4, replacing the old v3.6.3, indicating a minor site update.
    Difference
    0.0%
    Check dated 2026-07-25T13:13:16.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    A new page revision tag, v3.6.3, has been added to the study page, replacing the previous v3.6.2 tag. This represents an update to the page's versioning, indicating a newer revision of the study record.
    Difference
    0.0%
    Check dated 2026-07-03T22:41:35.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Revision: v3.6.2 replaces v3.6.0 on the page, indicating a backend software update; no visible content changes are implied by this revision tag.
    Difference
    0.0%
    Check dated 2026-06-26T20:51:49.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The SOPHIA study page now indicates that it is no longer recruiting participants. Enrollment is closed.
    Difference
    0.2%
    Check dated 2026-06-12T11:23:52.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    The page's revision tag was updated to v3.5.5, replacing the former v3.5.4 tag to reflect a new version of the page.
    Difference
    0.0%
    Check dated 2026-06-05T08:27:02.000Z thumbnail image

Stay in the know with updates to Margetuximab vs Trastuzumab in HER2+ Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Margetuximab vs Trastuzumab in HER2+ Metastatic Breast Cancer Clinical Trial page.